Glatiramer Acetate Injection, Solution
Product Images NDC 70710-1548

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 70710-1548). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 01)

Chemical structure of glatiramer acetate, showing the molecular components including various amino acids represented by their abbreviations and molecular formulas, with CAS number 147245-92-9 indicated.*

FDA Label Image

Figure 1 (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 02)

A Kaplan-Meier plot titled 'Time to Second Exacerbation' depicting the percentage of second exacerbations over time in days. The graph compares two groups: one treated with glatiramer acetate injection 20 mg/mL and the other with placebo. The vertical axis shows second exacerbation percentages from 0% to 55%, and the horizontal axis shows time in days up to 1080. The glatiramer acetate group curve rises more slowly than placebo, indicating fewer second exacerbations over time. Statistical data includes a p-value of 0.0005 and a hazard ratio of 0.55.*

FDA Label Image

Figure 2 (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 03)

A line graph titled 'Median Cumulative Number of Gd-Enhancing Lesions' compares glatiramer acetate injection to placebo over a 9-month period. The x-axis represents months 0 to 9, and the y-axis shows the median cumulative number of enhancing lesions from 0 to 18. Two lines are shown: a gray line for glatiramer acetate injection and a black line for placebo. The glatiramer acetate line rises more slowly, plateauing around 11 lesions around month 7, while the placebo line increases steadily to about 17 lesions by month 9.*

FDA Label Image

20 mg Carton Label (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 04)

Packaging label for Glatiramer Acetate Injection, 20 mg/mL, subcutaneous injection by Zydus Pharmaceuticals USA. The carton indicates 30 single-dose pre-filled syringes, for once daily use. It includes storage instructions and manufacturer/distributor information. The label features the NDC code 70710-1548-9 and specifies Rx only.*

FDA Label Image

40 mg Carton Label (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 05)

Carton packaging label for Glatiramer Acetate Injection 40 mg/mL, a subcutaneous injection solution. The label indicates a 12 single-dose pre-filled syringes package. It is manufactured by Zydus Pharmaceuticals USA Inc. The label includes dosage instructions stating "three times a week" and features a purple band with the NDC 70710-1549-6.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 10)

An instructional illustration labeled Figure I showing a hand holding a syringe with the needle pointed downward into a vial or container, demonstrating preparation or drawing of an injection dose.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 11)

An instructional illustration labeled 'Figure J' showing a hand placing or removing a syringe from a holder or a similar object. The drawing appears to be part of a series demonstrating proper handling or administration technique for an injection.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 12)

An instructional illustration labeled Figure K showing a hand pinching a fold of skin, likely demonstrating a step in the subcutaneous injection process for glatiramer acetate injection solution.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 13)

Illustration labeled Figure L showing a medical sharps disposal container with a biohazard symbol. The container is designed for safe disposal of medical needles or other sharps.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 2)

An instructional illustration showing components related to GLATIRAMER ACETATE injection use. It includes a sharps disposal container, syringe in blister package, cotton balls, alcohol wipes, and an injection diary, each labeled clearly around the central image of the sharps container.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 3)

Illustration showing hands holding and adjusting a syringe or injector device, labeled as Figure B in the instructional guide for GLATIRAMER ACETATE injection, solution. The image visually demonstrates a step in the preparation or administration process of the subcutaneous injection.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 4)

An instructional diagram showing recommended subcutaneous injection sites for glatiramer acetate. It includes the abdomen (avoiding 2 inches around the belly button), back of hips and arms (fleshy areas below the waist and upper arm portions), arms (upper back portion), and thighs (about 2 inches above the knee and 2 inches below the groin). Each area is visually shaded on simplified human figures.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 5)

An instructional illustration labeled 'Figure D' depicting a hand holding a small object, positioned near the inner side of the forearm, suggesting the action of preparing or administering a subcutaneous injection.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 6)

Illustration showing a hand holding a syringe in three sequential steps, demonstrating the process of removing the needle cap from the syringe prior to injection.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 7)

An instructional diagram depicting a person pinching and preparing the skin, likely for a subcutaneous injection. The illustration shows a hand grasping and lifting the skin fold on the abdomen area, demonstrating a typical step before administering an injection.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 8)

An instructional illustration showing a person administering a subcutaneous injection into the thigh. The hand is holding the syringe perpendicular to the skin surface, demonstrating proper injection technique for a glatiramer acetate injection solution.*

FDA Label Image

Image (F7c61e5d 41a8 4a49 Bc8e 4a00713f2a3e 98 9)

A medical illustration showing the administration of an injection into the upper thigh of an individual seated with legs crossed. One hand gently holds the thigh while the other holds a syringe positioned for subcutaneous injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.